Advanced search    

Search: authors:"Anoumou Dagnra"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo

Togo introduced monovalent rotavirus vaccine starting 19 June 2014. We compared all-cause acute gastroenteritis (AGE) hospitalizations and rotavirus-associated hospitalizations during the prevaccine period (July 2008–June 2014) to 1 year after vaccine introduction (July 2014–June 2015). The proportion of children with AGE who tested positive for rotavirus declined from 53% (645...

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance

Gehre 0 Jacob Otu 0 Lindsay Kendall 0 Audrey Forson Awewura Kwara Samuel Kudzawu Aderemi O. Kehinde Oludele Adebiyi Kayode Salako Ignatius Baldeh Aisha Jallow Mamadou Jallow Anoumou Dagnra Kodjo Dissé

National Surveillance Data on the Epidemiology of Cholera in Togo

Background. Togo is a cholera-endemic country bordered by other countries where this disease is endemic. We describe the epidemiology of cholera in Togo, using national surveillance data. Methods. We reviewed national surveillance data housed in the National Ministry of Health. Districts submitted reports of summary weekly case counts and deaths at the national level. Data were...

Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving Highly Antiretroviral Therapy and Monitored With the World Health Organization Public Health Approach in Sub-Saharan Africa and Southeast Asia

Background. The limited access to virological monitoring in developing countries is a major weakness of the current antiretroviral treatment (ART) strategy in these settings. We conducted a large cross-sectional study in Burkina Faso, Cameroon, Cote d'Ivoire, Senegal, Togo, Thailand, and Vietnam to assess virological failure and drug resistance mutations (DRMs) after 12 or 24...